| Healthcare expenditures for privately insured US patients with cystic fibrosis, 2010‐2016 SD Grosse, TQN Do, M Vu, LB Feng, JG Berry, GS Sawicki Pediatric pulmonology 53 (12), 1611-1618, 2018 | 39 | 2018 |
| Impact of revised Infectious Diseases Society of America and Society for Healthcare Epidemiology of America clinical practice guidelines on the treatment of Clostridium … CJ Clancy, D Buehrle, M Vu, MM Wagener, MH Nguyen Clinical Infectious Diseases 72 (11), 1944-1949, 2021 | 37 | 2021 |
| Assessment of Use and Safety of Edaravone for Amyotrophic Lateral Sclerosis in the Veterans Affairs Health Care System M Vu, K Tortorice, J Zacher, D Dong, K Hur, R Zhang, CB Good, ... JAMA Network Open 3 (10), e2014645-e2014645, 2020 | 26 | 2020 |
| Discontinuation of Statins in Veterans Admitted to Nursing Homes near the End of Life CT Thorpe, FE Sileanu, MK Mor, X Zhao, S Aspinall, M Ersek, S Springer, ... Journal of the American Geriatrics Society 68 (11), 2609-2619, 2020 | 22 | 2020 |
| Antihypertensive Deprescribing in Older Adult Veterans at End of Life Admitted to Veteran Affairs Nursing Homes M Vu, FE Sileanu, SL Aspinall, JD Niznik, SP Springer, MK Mor, X Zhao, ... Journal of the American Medical Directors Association 22 (1), 132-140. e5, 2021 | 21 | 2021 |
| Effectiveness of a Student Pharmacist–Led Telephone Follow-Up Intervention to Improve Hemoglobin A1C in Diabetic Patients SK Peasah, K Granitz, M Vu, B Jacob Journal of pharmacy practice 33 (6), 832-837, 2020 | 15 | 2020 |
| Hospital and health plan partnerships: the Affordable Care Act's impact on promoting health and wellness M Vu, A White, VP Kelley, JK Hopper, C Liu American health & drug benefits 9 (5), 269, 2016 | 14 | 2016 |
| Cost-effectiveness of increased influenza vaccination uptake against readmissions of major adverse cardiac events in the US SK Peasah, MI Meltzer, M Vu, DL Moulia, CB Bridges PloS one 14 (4), e0213499, 2019 | 12 | 2019 |
| Hypertension management in nursing homes: review of evidence and considerations for care M Vu, LJ Schleiden, ML Harlan, CT Thorpe Current hypertension reports 22, 1-14, 2020 | 11 | 2020 |
| Estimated Costs of Severe Adverse Drug Reactions Resulting in Hospitalization in the Veterans Health Administration SL Aspinall, M Vu, V Moore, R Jiang, A Au, M Bounthavong, PA Glassman JAMA network open 5 (2), e2147909-e2147909, 2022 | 9 | 2022 |
| Association between adverse events and discontinuation of antiepileptic drugs among drug-naïve adults with epilepsy SK Peasah, J Fishman, D Ems, M Vu, TVT Huynh, S Beaty Drugs-Real World Outcomes 8, 5-14, 2021 | 5 | 2021 |
| Exploratory Cost-Effectiveness Analysis for Treatment of Methicillin-Resistant Staphylococcus aureus Bloodstream Infections: Is Linezolid or Daptomycin Favored … M Vu, KJ Smith, SL Aspinall, CJ Clancy, DJ Buehrle Clinical Drug Investigation 41, 885-894, 2021 | 4 | 2021 |
| Know Your Numbers: Creation and implementation of a novel community health mobile application (app) by student pharmacists M Vu, V Nguyen, S Vishwanath, C Wolfe, S Patel Journal of the American Pharmacists Association 58 (2), 191-198. e2, 2018 | 3 | 2018 |
| Outpatient treatment and clinical outcomes of bacteriuria in veterans: A retrospective cohort analysis SA Rovelsky, M Vu, AK Barrett, K Bukowski, X Wei, M Burk, M Jones, ... Antimicrobial Stewardship & Healthcare Epidemiology 2 (1), e168, 2022 | 1 | 2022 |
| Future of Wellness and Medicare Part D: The Impact of Mergers and Acquisitions M Vu, A Lovett, V Kelley, J Hopper, C Liu | 1 | 2015 |
| Comparison of hospitalization costs for the same adverse reaction associated with different medications SA Alabbas, R Jiang, A Au, M Vu, VR Moore, FE Cunningham, K Stroupe, ... American Journal of Health-System Pharmacy 80 (12), 750-755, 2023 | | 2023 |
| Increased delay from initial concern to diagnosis of autism spectrum disorder and associated health care resource utilization and cost among children aged younger than 6 years … M Vu, AM Duhig, A Tibrewal, CM Campbell, A Gaur, C Salomon, A Gupta, ... Journal of Managed Care & Specialty Pharmacy 29 (4), 378-390, 2023 | | 2023 |
| Daptomycin likely cost effective compared with other regimens for MRSA blood infections in the USA M Vu PharmacoEconomics & Outcomes News 887, 12-18, 2021 | | 2021 |
| 286. Exploratory Cost-Effectiveness Analysis for Treatment of Methicillin-Resistant Staphylococcus aureus Bloodstream Infections: Are Daptomycin and Linezolid Favored over … M Vu, K Smith, SL Aspinall, CJ Clancy, D Buehrle Open Forum Infectious Diseases 7 (Suppl 1), S143, 2020 | | 2020 |
| Edaravone Utilization and Outcomes within a Nationally Integrated Health System (1199) K Tortorice, M Vu, XM Wei, D Dong, K Hur, J Zacher, F Cunningham, ... Neurology 94 (15 Supplement), 2020 | | 2020 |
Samuel K. PeasahDirector, HVHC UPMC Health Plan, Pittsburgh PAVerified email at upmc.edu
